Askim, Sweden

Per L Lindberg

This inventor holds 23 USPTO granted patents, primarily in Benzimidazole Derivatives. Top assignees: Aktiebolaget Hassle, Ab Hassle, Astra Lakemedel Aktiebolag. Active years: 1984-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per L Lindberg. Retrieved from https://idiyas.com/inventor/per-l-lindberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 235(Granted Patents)


Company Filing History:


Years Active: 1984-1995

Loading Chart...
Areas of Expertise:
Benzimidazole
Pharmacological Compounds
Fluoro Substituted
Therapeutically Active
Anti-Ulcer Agents
Pyridinyl Derivatives
Cyclopropyl Compounds
Aminotetralin Derivatives
Dopaminergic Activity
Tricyclic Amines
Chloro Substituted
Phenyl Piperidines
23 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Per L Lindberg

Introduction: Per L Lindberg, based in Askim, Sweden, is a notable inventor with an impressive portfolio of 23 patents to his name. His work primarily revolves around the development of novel compounds with significant therapeutic applications, particularly in the field of pharmaceuticals.

Latest Patents: Among his recent inventions, Lindberg has patented therapeutically active fluoro-substituted benzimidazoles. These novel compounds, characterized by their unique formulas, feature groups that provide potential medicinal benefits. His findings include intermediates and pharmaceutical compositions that utilize these compounds as active ingredients. Another significant patent of his is for dialkoxy-pyridinyl-benzimidazole derivatives, which outline new chemical structures along with their physiologically acceptable salts, demonstrating his ongoing commitment to innovation in the pharmaceutical sector.

Career Highlights: Throughout his career, Lindberg has made substantial contributions to the pharmaceutical industry, developing innovative compounds that aid in medical treatments. He has worked with reputable companies, including Aktiebolaget Hassle, where he honed his expertise in drug development and patenting processes.

Collaborations: Lindberg has collaborated with esteemed colleagues, such as Gunnel E Sunden and Arne E Brandstrom. Their combined efforts in research and development have led to advancements in the pharmaceutical patenting arena, supporting the growth of innovative drug therapies.

Conclusion: Per L Lindberg's contributions to the field of pharmaceuticals are marked by his substantial patent portfolio and collaborative efforts. As an inventor, he continues to influence the development of therapeutic compounds, paving the way for future innovations in medicine. His work exemplifies the spirit of innovation necessary for the advancement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…